Lysosomal lipid accumulation is a ubiquitous but poorly understood aspect of atherosclerosis in man and susceptible animals. The importance of this accumulation is suggested by its spatial and temporal association with important events in development of lesions from fatty streaks to plaques. Moreover, lysosomally sequestered cholesterol in lesion cells appears trapped and less available for efflux than that in cytoplasmic stores. Prolonged incubation of pigeon and THP1 macrophages (a human cell line) with oxidized (ox-) LDL produces accumulation of both free (FC) and esterified cholesterol (CE) in lysosomes similar to that in lesions. Morphological and biochemical studies show that an initial build up of lysosomal FC is followed by lysosomal CE accumulation. This suggests that initially, lipoprotein CE is hydrolyzed to FC but that subsequent to this, hydrolysis is impaired. We hypothesize that lysosomal FC accumulation, produced by inhibition of FC movement out of lysosomes, is a mediator of the impairment of hydrolysis. This proposal will test this hypothesis in order to define mechanism(s) of lysosomal accumulation. Using a combination of biochemical and structural tools the effects of lysosomal FC accumulation on lysosomal CE hydrolysis and exit of FC from lysosomes will be explored. Treatment of human cells with acetylated (ac-)LDL does not produce lysosomal accumulation, even in cells with equivalent cholesterol levels. Differences in responses of cells to ox- or ac-LDL loading will be used to identify potentially important factors for lysosomal engorgement. Mouse macrophages do not exhibit lysosomal loading with either ox- or ac-LDL. Based on this observation, suspected factors, principally FC, will be tested for the ability to induce lysosomal loading in mouse cells. Finally, specific lysosomal factors, such as sphingomyelin content or enzyme trafficking will be examined for the ability to trap FC and/or inhibit hydrolysis. This will determine the potential of these suspected factors under culture conditions to mediate lysosomal lipid accumulation. The analytical approach of integrating quantitative microscopic and biochemical data is designed to provide a broader analysis of the cellular consequences of specific manipulations. Completion of the aims will significantly expand understanding of lysosomal FC and CE accumulation and provide information to begin determining the role of this accumulation in atherogenesis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
7R01HL049148-06
Application #
6423072
Study Section
Pathology A Study Section (PTHA)
Project Start
1995-05-01
Project End
2003-06-30
Budget Start
2001-01-01
Budget End
2001-06-30
Support Year
6
Fiscal Year
2000
Total Cost
$195,315
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Pathology
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Chen, Bin; Ren, Xuefeng; Neville, Tracey et al. (2009) Apolipoprotein AI tertiary structures determine stability and phospholipid-binding activity of discoidal high-density lipoprotein particles of different sizes. Protein Sci 18:921-35
Ullery-Ricewick, Jody C; Cox, Brian E; Griffin, Evelyn E et al. (2009) Triglyceride alters lysosomal cholesterol ester metabolism in cholesteryl ester-laden macrophage foam cells. J Lipid Res 50:2014-26
Jerome, W Gray; Cox, Brian E; Griffin, Evelyn E et al. (2008) Lysosomal cholesterol accumulation inhibits subsequent hydrolysis of lipoprotein cholesteryl ester. Microsc Microanal 14:138-49
Zhang, Yonghong; Vasudevan, Sheeja; Sojitrawala, Radiya et al. (2007) A monomeric, biologically active, full-length human apolipoprotein E. Biochemistry 46:10722-32
Cox, Brian E; Griffin, Evelyn E; Ullery, Jody C et al. (2007) Effects of cellular cholesterol loading on macrophage foam cell lysosome acidification. J Lipid Res 48:1012-21
Jerome, W Gray (2006) Advanced atherosclerotic foam cell formation has features of an acquired lysosomal storage disorder. Rejuvenation Res 9:245-55
Ren, Xuefeng; Zhao, Lei; Sivashanmugam, Arun et al. (2005) Engineering mouse apolipoprotein A-I into a monomeric, active protein useful for structural determination. Biochemistry 44:14907-19
Griffin, Evelyn E; Ullery, Jody C; Cox, Brian E et al. (2005) Aggregated LDL and lipid dispersions induce lysosomal cholesteryl ester accumulation in macrophage foam cells. J Lipid Res 46:2052-60
Dove, Dwayne E; Su, Yan Ru; Zhang, Wenwu et al. (2005) ACAT1 deficiency disrupts cholesterol efflux and alters cellular morphology in macrophages. Arterioscler Thromb Vasc Biol 25:128-34
Jerome, W Gray; Handt, Stefan; Hantgan, Roy R (2005) Endothelial cells organize fibrin clots into structures that are more resistant to lysis. Microsc Microanal 11:268-77

Showing the most recent 10 out of 20 publications